SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients.

BMC Neurol · 2005-06-20

DOI: 10.1186/1471-2377-5-11PMID: 15967032

Open accessComparative Study; Research Support, Non-U.S. Gov't; research-article; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

BackgroundFibroblast growth factor 20 (FGF20) is a neurotrophic factor preferentially expressed in the substantia nigra of rat brain and could be involved in dopaminergic neurons survival. Recently, a strong genetic association has been found between FGF20 gene and the risk of suffering from Parkinson's disease (PD). Our aim was to replicate this association in two independent populations.MethodsAllelic, genotypic, and haplotype frequencies of four biallelic polymorphisms were assessed in 151 sporadic PD cases and 186 controls from Greece, and 144 sporadic PD patients and 135 controls from Finland.ResultsNo association was found in any of the populations studied.ConclusionTaken together, these findings suggest that common genetic variants in FGF20 are not a risk factor for PD in, at least, some European populations.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.